<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>SCOPE: We previously found that curcuminoids decreased blood <z:chebi fb="105" ids="17234">glucose</z:chebi> and improved <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> by reducing serum free fatty acids (FFAs) and increasing fatty acid oxidation in skeletal muscle of diabetic rats </plain></SENT>
<SENT sid="1" pm="."><plain>This study was to investigate whether curcuminoids have beneficial effects on type 2 diabetic patients, and its possible mechanisms </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: Overweight/<z:mp ids='MP_0001261'>obese</z:mp> type 2 diabetic patients (BMI ≥ 24.0; fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi> ≥ 7.0 mmol/L or postprandial blood <z:chebi fb="105" ids="17234">glucose</z:chebi> ≥11.1 mmol/L) were randomly assigned to curcuminoids (300 mg/day) or placebo for 3 months </plain></SENT>
<SENT sid="3" pm="."><plain>Bodyweight, glycosylated <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> A(1c) (HbA(1c) ,(%) ), serum fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, FFAs, <z:chebi fb="23" ids="18059">lipids</z:chebi>, and <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> lipase (LPL) were determined </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 100 patients (curcuminoids, n = 50; placebo, n = 50) completed the trial </plain></SENT>
<SENT sid="5" pm="."><plain>Curcuminoids supplementation significantly decreased fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi> (p &lt; 0.01), HbA(1c) (p = 0.031), and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> index (HOMA-IR) (p &lt; 0.01) in type 2 diabetic patients </plain></SENT>
<SENT sid="6" pm="."><plain>Curcuminoids also led to a significant decrease in serum total FFAs (p &lt; 0.01), <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (P = 0.018), an increase in LPL activity (p &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: These findings suggest a <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering effect of curcuminoids in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, which is partially due to decrease in serum FFAs, which may result from promoting fatty acid oxidation and utilization </plain></SENT>
</text></document>